遗传异常预测了核心结合因子急性髓性白血病患者的结果
Shunjie Yu1, Sen Yang1, Lijuan Hu1
1Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Peking University, No. 11 Xizhimen South St, Beijing, China.
这项研究整合了核心结合因子急性髓性白血病 (CBF-AML) 患者的临床和基因组数据. 像KDM6A和FLT3这样的特定突变影响生存,而ASXL1突变在RUNX1::RUNX1T1.1中显示出有利的预后.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 核心结合因子急性髓性白血病 (CBF-AML) 是一个独特的亚型,具有特定的遗传改变.
- 在CBF-AML中对临床和基因组数据的全面整合是有限的,这阻碍了精确的预后评估.
- 了解预后标志物对于定制CBF-AML治疗策略至关重要.
研究的目的:
- 研究CBF-AML的临床和基因组特征与患者结局之间的关联.
- 为了确定特定的突变和临床因素,预测无事件生存 (EFS),无复发生存 (RFS) 和CBF-AML亚型的整体生存 (OS).
- 为CBF-AML患者提供更精细的预后模型.
主要方法:
- 来自346名CBF-AML患者的临床和基因组数据的回顾性审查.
- 患者被分为RUNX1::RUNX1T1 (n=211) 和CBFB::MYH11 (n=135) 队列.
- 考克斯回归模型被用来分析变量与生存结果 (EFS,RFS,OS) 之间的关联.
主要成果:
- 在RUNX1::RUNX1T1队列中,KDM6A突变与较差的RFS和OS有关,FLT3-TKD突变与较差的OS有关,高KIT突变VAF (>25%) 与较差的RFS有关.
- 在RUNX1::RUNX1T1队列中,ASXL1突变与有利的EFS和OS有关.
- 在CBFB::MYH11队列中,高突变负担和FLT3-ITD突变与劣质的OS相关. 随着年龄的增长,非密集化疗和高MRD水平也预测了RUNX1::RUNX1T1队列的不良结果.
结论:
- 特定突变 (KDM6A,FLT3,KIT) 和临床因素 (年龄,化疗强度,MRD) 显著影响CBF-AML的结果.
- 在RUNX1::RUNX1T1亚型中,ASXL1突变代表了有利的预后标记.
- 高突变负担是CBFB::MYH11亚型的不良预后因素,突出了综合基因组和临床分析对于个性化CBF-AML管理的重要性.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
相关概念视频
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Differentiation of Common Myeloid Progenitor Cells
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Regulation of Hematopoietic Stem Cells
